Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

First results for KSQ-4279 in treatment of BRCA-deficient cancers

Nov. 5, 2020

Calithera expands phase I/II trial of telaglenastat with palbociclib to include pancreatic cancer

Nov. 5, 2020

Discovery of novel DNA-PK inhibitors as radiosensitizers

Nov. 5, 2020

Roche identifies new monoglyceride lipase inhibitors

Nov. 5, 2020

New wee1-like protein kinase inhibitors discovered at Nuvation Bio

Nov. 5, 2020

Biodistribution, dosimetry and preclinical efficacy data presented for [177Lu]rhPSMA-7.3

Nov. 4, 2020

Serine deprivation spurs selective translation in pancreatic cancer

Nov. 4, 2020

Nuvation Bio describes new Wee1 inhibitors

Nov. 4, 2020

Nurix Therapeutics patents CBLB inhibitors

Nov. 4, 2020

FDA clears IND application for phase I/II study of EG-70 in NMIBC

Nov. 4, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...